Lymphoadenopathy in IL-2-deficient mice: Further characterization and overexpression of the antiapoptotic molecule cellular FLIP

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3644-3651

  Chastagner, Patricia ^a   Reddy, Jay ^a   Thèze, Jacques ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 8; CASPASE 8 INHIBITORY PROTEIN; COMPLEMENTARY DNA; CYTOKINE; FLICE INHIBITORY PROTEIN; INTERLEUKIN 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0036785617     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3644     Document Type: Article

References (33)

1. Smith, K. A. 1988. Interleukin-2: inception, impact and implications. Science 240:1169.
2. Thèze, J., P. M. Alzari, and J. Bertoglio. 1996. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today 17:481.
3. Schorle, H., T. Holtschke, T. Hünig, A. Schimpl, and I. Horak, 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
4. Li, X. C., G. Demirci, S. Ferrari-Lacraz, C. Groves, A. Coyle, T. R. Malek, and T. B. Strom. 2001. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat. Med. 7:114.
5. Herblot, S., P. Chastagner, L. Samady, J. L. Moreau, C. Demaison, P. Froussard, X. Liu, J. Bonnet, and J. Thèze. 1999. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J. Immunol. 162:3280.
6. Kneitz, B. B., T. Herrmann, S Yonehara, and A. Schimpl. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25:2572.
7. Reddy, J., P. Chastagner, L. Fiette, X. Liu, and J. Thèze. 2000. IL-2-induced tumor necrosis factor (TNF)-β expression: further analysis in the IL-2 knockout model, and comparison with TNF-α, lymphotoxin-β, TNFR1 and TNFR2 modulation. Int. Immunol. 13:135.
8. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
9. Thome, M., and J. Tschopp. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1:50.
10. Refaeli, Y., L. V. Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
11. Tschopp, J., M. Irmler, and M. Thorne. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552.
12. Moreau, J. L., M. Nabholz, T. Diamantstein, T. Malek, E. Shevach, and J. Thèze. 1987. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin-2 receptor: relationship to the interleukin-2 binding site. Eur. J. Immunol. 17:929.
13. Hamel, W., P. Dazin, and M. A. Israel. 1996. Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173.
14. Weil, R., H. Sirma, C. Giannini, D. Kremsdorf, C. Bessia, C. Dargemont, C. Bréchot, and A. Israël. 1999. Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα. Mol. Cell. Biol. 19:6345.
15. H1 gene family expression in peripheral B cell IgA, IgD and IgG during HIV infection. Eur. J. Immunol. 25:1524.
16. Demaison, C., L, Fiette, V. Blanchetière, A. Schimpl, J. Thèze, and P. Froussard. 1998. IL-2 receptor α-chain expression is independently regulated in primary and secondary lymphoid organs. J. Immunol. 161:1977.
17. Fitzpatrick, J. M., J. S. Koh, D. I. Beller, and J. S. Levine. 1996. Dysregulated cytokine in vivo in prediseased and diseased autoimmune-prone MRL mice. Autoimmunity 23:217.
18. Irmler, M., M. Thorne, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
19. Algeciras-Schimnich, A., T. S. Griffith, D. H. Lynch, and C. V. Paya. 1999. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162:5205,
20. Yeh, J. H., S. C. Hsu, S. H. Han, and M. Z. Lai. 1998. Mitogen-activated protein kinase antagonized as-associated death domain protein-mediated apoptosis by induced FLlCE-inhibitory protein expression. J. Exp. Med. 188:1795.
21. Inaba, M., K. Kurasawa, M. Mamura, K. Kumano, Y. Saito, and I. Iwamoto. 1999. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J. Immunol. 163:1315.
22. Kirchhoff, S., W. W. Müller, A. Krueger, I. Schmitz, and P. H. Krammer. 2000. TCR-mediated up-regulation of c-FLIP short correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165:6293.
23. Kataoka, T., R. C. Budd, N. Holler, M. Thorne, F. Martinon. M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10:640.
24. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
25. Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-Ipr/Ipr mouse. Eur. J. Immunol. 20:163.
26. Sadlack, B., J. Lohler, H. Schorle, G. Klebb, H. Haber, E. Sickel, R. J. Noelle, and I. Horak. 1995. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25:3053.
27. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
28. Hunig, T., and A. Schimpl. 1997. Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr. Opin. Immunol. 9:826.
29. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637.
30. Papiernik, M., M. D. Moraes, C. Pontoux, F. Vasseur, and C. Penit. 1998. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10:371.
31. + regulatory T cells: their role in the control of superantigen responses. Immunol. Rev. 182:180.
32. + suppressor T cells. Immunol. Rev. 182:58.
33. Parijs, L. V., Y. Refaeli, A. K. Abbas, and D. Baltimore. 1999. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes. Immunity 11:763.